Skip to main content
Skip to main content
BCHI logo

GMO Beyond China ETF (BCHI)

$38.03 +$0.00 (+0.00%) |CouncilHOLD · 47 · C
Bottom line: HOLD — our Council read (47/100) and AI Score (47/100) broadly agree.
MCap: $19.34M| Vol: 28|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

GMO Beyond China ETF (BCHI) trades at $38.03 with AI Score 47/100 (Grade C). The GMO Beyond China ETF (BCHI) aims to provide total return by investing in equities of companies poised to benefit from supply chain diversification away from China. Market cap: $19.34M, Sector: Financial services.

Price live · AI analysis from Jun 1, 2026
The GMO Beyond China ETF (BCHI) aims to provide total return by investing in equities of companies poised to benefit from supply chain diversification away from China. The fund excludes Chinese securities, focusing on companies in other emerging markets.

Analyst Coverage for BCHI: BCHI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BCHI against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 47/100 · C

BCHI: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

GMO Beyond China ETF (BCHI) Financial Services Profile

HeadquartersBoston, US
IPO Year2025

GMO Beyond China ETF (BCHI) offers investors exposure to companies benefiting from the diversification of global supply chains away from China. The fund strategically invests in equities, excluding Chinese securities, to capture growth in emerging markets and aims to deliver total return.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 1, 2026

What Is the Investment Thesis for BCHI?

The GMO Beyond China ETF (BCHI) presents an investment opportunity centered on the ongoing shift in global supply chains. As companies seek to reduce reliance on China, BCHI is positioned to benefit by investing in companies that stand to gain from this diversification. The fund's value drivers include the increasing attractiveness of alternative manufacturing hubs in Southeast Asia, India, and Latin America. Catalysts for growth include continued geopolitical tensions, rising labor costs in China, and government incentives in other countries to attract foreign investment. However, potential risks include slower-than-expected supply chain shifts, increased competition among beneficiary countries, and broader economic downturns affecting global trade. With a beta of 1.05, the fund exhibits market-level volatility. Investors may want to evaluate these factors when evaluating BCHI's potential for long-term returns.

Based on FMP financials and quantitative analysis

BCHI Key Highlights

  • The fund focuses on companies benefiting from the diversification of global supply chains away from China.
  • BCHI excludes direct investments in Chinese securities, mitigating exposure to specific geopolitical and economic risks associated with China.
  • The ETF's investment strategy involves a rigorous selection process, analyzing companies based on their potential to gain from supply chain diversification.
  • BCHI aims to deliver long-term total return to its investors through a diversified portfolio of companies across various sectors and geographies.
  • The fund is managed by experienced portfolio managers who actively monitor market conditions and adjust the portfolio as needed to optimize performance and manage risk.

Who Are BCHI's Competitors?

BCHI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
NXDT NexPoint Diversified Real Estate Trust $5.53 +3.08% $285.77M 73
GENB Generate Biomedicines, Inc. $17.03 -2.18% $2.18B 72
SII Sprott Inc. $118.11 +2.72% $3.05B 71
TPZ Tortoise Electrification Infrastructure ETF $21.82 +0.74% $128.52M 70
TRNGF The Trendlines Group Ltd. $0.03 +2.95% $28.87M 62
ARES Ares Management Corporation $121.81 +4.20% $40.01B 62
DIAX Nuveen Dow 30 Dynamic Overwrite Fund $14.10 -0.91% $512.77M 62
MPA BlackRock MuniYield Pennsylvania Quality Fund $11.39 +0.04% $147.56M 62

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BCHI's Key Strengths?

  • Targeted investment strategy focused on a specific market trend.
  • Exclusion of Chinese securities mitigates specific geopolitical and economic risks.
  • GMO's established research capabilities and expertise.
  • Experienced portfolio management team.

What Are BCHI's Weaknesses?

  • Relatively small market capitalization ($0.02B).
  • Concentrated investment focus may limit diversification.
  • Dependence on the continuation of the supply chain diversification trend.
  • No dividend yield may deter some investors.

What Could Drive BCHI Stock Higher?

  • Geopolitical tensions continue to drive supply chain diversification away from China.
  • Rising labor costs in China make other emerging markets more attractive.
  • Government incentives in other countries are expected to attract more foreign investment in the next 1-2 years.
  • Technological advancements in manufacturing reduce costs in diversified locations.

What Are the Key Risks for BCHI?

  • Slower-than-expected supply chain shifts could reduce demand for the fund.
  • Increased competition among beneficiary countries may erode profit margins.
  • Broader economic downturns could negatively impact global trade and investment.
  • Changes in government policies could impact supply chains and investment flows.
  • Medium risk rating indicates potential volatility and market sensitivity.

What Are the Growth Opportunities for BCHI?

  • Increased Geopolitical Tensions: Ongoing geopolitical tensions between major economic powers are accelerating the diversification of supply chains. Companies are actively seeking alternative manufacturing locations to mitigate risks associated with trade disputes and political instability. This trend benefits the GMO Beyond China ETF (BCHI) by increasing the demand for investments in companies positioned to gain from this shift. The market size for supply chain diversification is estimated to reach hundreds of billions of dollars over the next decade, providing a substantial growth opportunity for BCHI.
  • Rising Labor Costs in China: The increasing cost of labor in China is making other emerging markets more attractive for manufacturing. Companies are relocating production facilities to countries with lower labor costs, such as Vietnam, India, and Mexico. This trend is expected to continue, driving further diversification of supply chains and benefiting the GMO Beyond China ETF (BCHI). The timeline for this growth opportunity is ongoing, with labor costs in China projected to continue rising in the coming years.
  • Government Incentives in Other Countries: Governments in various countries are offering incentives to attract foreign investment and promote local manufacturing. These incentives include tax breaks, subsidies, and infrastructure development. Such initiatives are encouraging companies to diversify their supply chains and establish operations in these countries. The GMO Beyond China ETF (BCHI) is well-positioned to benefit from this trend by investing in companies that are taking advantage of these incentives. This growth opportunity is expected to unfold over the next 3-5 years.
  • Technological Advancements in Manufacturing: Advancements in automation and robotics are reducing the cost of manufacturing in developed and emerging markets. This is making it more feasible for companies to diversify their supply chains and establish production facilities in multiple locations. The GMO Beyond China ETF (BCHI) can capitalize on this trend by investing in companies that are adopting these technologies and expanding their operations outside of China. The market for advanced manufacturing technologies is projected to grow significantly over the next decade, providing a long-term growth opportunity for BCHI.
  • Growing Demand for ESG Investments: Environmental, social, and governance (ESG) factors are playing an increasingly important role in investment decisions. Companies are under pressure to ensure that their supply chains are sustainable and ethical. This is driving demand for investments in companies that are committed to ESG principles and have diversified their supply chains to reduce reliance on countries with poor ESG track records. The GMO Beyond China ETF (BCHI) can attract ESG-focused investors by highlighting its investments in companies with strong ESG profiles. The market for ESG investments is growing rapidly, providing a significant growth opportunity for BCHI.

What Opportunities Does BCHI Have?

  • Growing demand for specialized investment strategies.
  • Increasing awareness of geopolitical risks associated with China.
  • Rising labor costs in China driving further supply chain diversification.
  • Government incentives in other countries attracting foreign investment.

What Threats Does BCHI Face?

  • Slower-than-expected supply chain shifts.
  • Increased competition among beneficiary countries.
  • Broader economic downturns affecting global trade.
  • Changes in government policies impacting supply chains.

What Are BCHI's Competitive Advantages?

  • Specialized investment strategy focused on a specific market trend.
  • Exclusion of Chinese securities differentiates the fund from broader emerging market ETFs.
  • GMO's established research capabilities and expertise in global equity markets.
  • Experienced portfolio managers with a track record of managing similar investment strategies.

What Does BCHI Do?

The GMO Beyond China ETF (BCHI) was created to capitalize on the growing trend of companies diversifying their supply chains away from China. Recognizing the increasing geopolitical and economic risks associated with concentrating supply chains in a single country, GMO launched this ETF to provide investors with a targeted investment vehicle. The fund focuses on identifying and investing in companies that are positioned to benefit from this shift, excluding direct investments in Chinese securities. The ETF's investment strategy involves a rigorous selection process, analyzing companies based on their potential to gain from supply chain diversification. This includes assessing their operational footprint, growth prospects, and financial stability. By investing in a diversified portfolio of companies across various sectors and geographies, the GMO Beyond China ETF aims to deliver long-term total return to its investors. The fund's investment approach is underpinned by GMO's established research capabilities and expertise in global equity markets. The ETF is managed by experienced portfolio managers who actively monitor market conditions and adjust the portfolio as needed to optimize performance and manage risk. The fund is available to investors seeking exposure to the supply chain diversification trend without directly investing in Chinese equities.

What Products and Services Does BCHI Offer?

  • Invests in equities of companies positioned to benefit from supply chain diversification.
  • Excludes direct investments in Chinese securities.
  • Seeks to deliver total return to investors.
  • Analyzes companies based on their potential to gain from supply chain diversification.
  • Manages a diversified portfolio of companies across various sectors and geographies.
  • Monitors market conditions and adjusts the portfolio as needed to optimize performance and manage risk.

How Does BCHI Make Money?

  • The fund generates revenue through management fees charged to investors.
  • The management fee is a percentage of the fund's assets under management (AUM).
  • The fund's profitability depends on its ability to attract and retain investors.
  • The fund's performance influences its ability to attract new investors.

What Industry Does BCHI Operate In?

The global asset management industry is undergoing significant transformation, driven by factors such as increasing demand for specialized investment strategies and growing awareness of geopolitical risks. The trend of supply chain diversification is reshaping the competitive landscape, with companies seeking to reduce reliance on single-country sourcing. The GMO Beyond China ETF (BCHI) operates within this context, offering a targeted investment solution for investors seeking to capitalize on this trend. The global ETF market is projected to reach trillions in assets under management, with specialized ETFs like BCHI gaining traction due to their focused investment mandates.

Who Are BCHI's Key Customers?

  • Retail investors seeking exposure to the supply chain diversification trend.
  • Institutional investors looking for targeted investment solutions.
  • Financial advisors seeking to diversify client portfolios.
  • ESG-focused investors interested in sustainable supply chains.
AI Confidence: 66% Updated: Jun 1, 2026

BCHI Valuation & Market Position

With a $19.34M market cap, GMO Beyond China ETF sits in the micro-cap segment of the market. Relative to its peer group, BCHI's quantitative score of 47/100 is below the peer average of 70/100.

ROE 0%Key Financial Metrics

Return on equity for GMO Beyond China ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. BCHI trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

BCHI Financials

Bull Case vs Bear Case

Bull Case

  • Targeted investment strategy focused on a specific market trend.
  • Exclusion of Chinese securities mitigates specific geopolitical and economic risks.
  • GMO's established research capabilities and expertise.
  • Experienced portfolio management team.

Bear Case

  • Relatively small market capitalization ($0.02B).
  • Concentrated investment focus may limit diversification.
  • Dependence on the continuation of the supply chain diversification trend.
  • No dividend yield may deter some investors.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

BCHI Latest News

No recent news available for BCHI.

BCHI Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BCHI.

Price Targets

Wall Street price target analysis for BCHI.

BCHI MoonshotScore

47/100

What does this score mean?

The MoonshotScore rates BCHI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

BCHI Financial Services Stock FAQ

What does GMO Beyond China ETF do?

The GMO Beyond China ETF (BCHI) is designed to provide investors with exposure to companies that are expected to benefit from the ongoing trend of supply chain diversification away from China. The fund invests primarily in the equities of companies located outside of China that are positioned to gain from this shift. By excluding Chinese securities, BCHI aims to offer a targeted investment solution for those seeking to capitalize on the changing global economic landscape, focusing on total return through strategic equity investments in emerging markets.

What do analysts say about BCHI stock?

As of 2026-06-01, analyst coverage of GMO Beyond China ETF (BCHI) is limited due to its relatively small market capitalization. However, the fund's focus on the supply chain diversification trend is generally viewed positively. Key valuation metrics are not widely available, but investors may want to evaluate the fund's expense ratio and tracking error relative to its benchmark. Growth considerations include the pace of supply chain shifts, geopolitical factors, and the performance of beneficiary countries. Investors should conduct their own due diligence before investing.

What are the main risks for BCHI?

The main risks for GMO Beyond China ETF (BCHI) include the potential for slower-than-expected supply chain shifts, which could reduce demand for the fund. Increased competition among beneficiary countries may also erode profit margins for the companies in which the fund invests. Broader economic downturns could negatively impact global trade and investment, affecting the fund's performance. Additionally, changes in government policies could impact supply chains and investment flows. The fund's medium risk rating indicates potential volatility and market sensitivity.

What are the key factors to evaluate for BCHI?

GMO Beyond China ETF (BCHI) holds an AI score of 47/100 (low). Not financial advice.

How frequently does BCHI data refresh on this page?

BCHI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven BCHI's recent stock price performance?

GMO Beyond China ETF (BCHI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Targeted investment strategy focused on a specific market trend. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BCHI overvalued or undervalued right now?

Valuing GMO Beyond China ETF (BCHI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying BCHI?

Before investing in GMO Beyond China ETF (BCHI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The analysis is based on limited publicly available information.
  • The fund's performance is subject to market risks and fluctuations.
  • The supply chain diversification trend is subject to change and uncertainty.
Data Sources

Popular Stocks